Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 12 | $12,762,122 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Feb 2024 17:40 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 13 Feb 2024 | Sale | 1,352 | 132.8947 | 179,674 | D |
08 Feb 2024 19:17 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 08 Feb 2024 | Sale | 980 | 134.2032 | 131,519 | D |
08 Feb 2024 19:17 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 06 Feb 2024 | Sale | 1,600 | 142.2013 | 227,522 | D |
02 Feb 2024 19:17 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 31 Jan 2024 | Sale | 1,541 | 140.696 | 216,813 | D |
04 Jan 2024 18:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 02 Jan 2024 | Sale | 6,116 | 131.4429 | 803,905 | D |
04 Jan 2024 18:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 02 Jan 2024 | Sale | 68,884 | 131.4716 | 9,056,290 | D |
23 Aug 2023 20:05 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 21 Aug 2023 | Sale | 2,132 | 107.4075 | 228,993 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 08 Feb 2023 | Sale | 980 | 103.9898 | 101,910 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 12,801 | 102.4114 | 1,310,968 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 1,623 | 102.2884 | 166,014 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 06 Feb 2023 | Sale | 1,600 | 105.6422 | 169,028 | D |
02 Feb 2023 17:15 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 31 Jan 2023 | Sale | 1,541 | 109.9847 | 169,486 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)